@article{1e01a0d7328c42d4adc544a9a0e993d9,
title = "Governmental, national, international agency and other initiatives to advance the application of cellular therapies",
author = "Sharp, {J. G.}",
note = "Funding Information: Cellular therapy has always been at the leading edge of medical technology and, consequently, has been controversial. The pioneering studies of Dr Donnal Thomas and colleagues applying high-dose therapy for leukemia, which required allogeneic BMT to restore hematopoiesis [ 1 ], were the subject of contemporary concerns and multiple disappointments [ 2 ]. Government grant support was important to this effort. It was many years after the evident success of this therapeutic modality, for the treatment of otherwise fatal diseases, that the innovation was recognized with the award of the Nobel Prize for Physiology and Medicine to Dr Thomas in 1990 [ 3 ]. ",
year = "2005",
doi = "10.1080/14653240500238319",
language = "English (US)",
volume = "7",
pages = "315--316",
journal = "Cytotherapy",
issn = "1465-3249",
publisher = "Elsevier B.V.",
number = "4",
}